Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 461

1.

Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk. Final rule.

Food and Drug Administration, HHS.

Fed Regist. 2004 Feb 11;69(28):6787-854.

PMID:
14968803
[PubMed - indexed for MEDLINE]
Free Article
2.

Dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk; final rule.

Food and Drug Administration, Public Health Service, U.S. Department of Health and Human Services.

J Pain Palliat Care Pharmacother. 2004;18(3):95-107.

PMID:
15364637
[PubMed - indexed for MEDLINE]
3.

Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids.

Haller CA, Benowitz NL.

N Engl J Med. 2000 Dec 21;343(25):1833-8.

PMID:
11117974
[PubMed - indexed for MEDLINE]
Free Article
4.

Ephedrine alkaloids banned from dietary supplements.

Thompson CA.

Am J Health Syst Pharm. 2004 Apr 15;61(8):750-2, 756. No abstract available.

PMID:
15127956
[PubMed - indexed for MEDLINE]
5.
6.

Ephedra ban: no shortage of reasons.

Rados C.

FDA Consum. 2004 Mar-Apr;38(2):6-7.

PMID:
15101356
[PubMed - indexed for MEDLINE]
Free Article
7.

Medicine. Ephedra--scientific evidence versus money/politics.

Wolfe SM.

Science. 2003 Apr 18;300(5618):437. No abstract available. Erratum in: Science. 2003 May 21;300(5621):905.

PMID:
12702860
[PubMed - indexed for MEDLINE]
8.

Ephedra: yesterday, DSHEA, and tomorrow--a ten year perspective on the Dietary Supplement Health and Education Act of 1994.

Seamon MJ, Clauson KA.

J Herb Pharmacother. 2005;5(3):67-86. Review.

PMID:
16520299
[PubMed - indexed for MEDLINE]
9.

The need for regulation of dietary supplements--lessons from ephedra.

Fontanarosa PB, Rennie D, DeAngelis CD.

JAMA. 2003 Mar 26;289(12):1568-70. Epub 2003 Mar 10. No abstract available.

PMID:
12672775
[PubMed - indexed for MEDLINE]
10.

Safety concerns regarding ephedrine-type alkaloid-containing dietary supplements.

Miller SC.

Mil Med. 2004 Feb;169(2):87-93. Review.

PMID:
15040625
[PubMed - indexed for MEDLINE]
11.

FDA v. ephedra: is it time to lift the ban?

Pyle KR.

Food Drug Law J. 2006;61(4):701-51. No abstract available.

PMID:
17180770
[PubMed - indexed for MEDLINE]
12.

Ephedra: once a boon, now a bane.

Scheindlin S.

Mol Interv. 2003 Oct;3(7):358-60. No abstract available.

PMID:
14993455
[PubMed - indexed for MEDLINE]
13.

Concentrations of ephedra alkaloids and caffeine in commercial dietary supplements.

Haller CA, Duan M, Benowitz NL, Jacob P 3rd.

J Anal Toxicol. 2004 Apr;28(3):145-51.

PMID:
15107143
[PubMed - indexed for MEDLINE]
Free Article
14.

Ephedra and ephedrine for weight loss and athletic performance enhancement: clinical efficacy and side effects.

Shekelle P, Hardy ML, Morton SC, Maglione M, Suttorp M, Roth E, Jungvig L, Mojica WA, Gagné J, Rhodes S, McKinnon E.

Evid Rep Technol Assess (Summ). 2003 Mar;(76):1-4. No abstract available.

PMID:
12647510
[PubMed - indexed for MEDLINE]
Free Article
15.

FDA regulation of dietary supplements and requirements regarding adverse event reporting.

Frankos VH, Street DA, O'Neill RK.

Clin Pharmacol Ther. 2010 Feb;87(2):239-44. doi: 10.1038/clpt.2009.263. Epub 2009 Dec 23.

PMID:
20032973
[PubMed - indexed for MEDLINE]
16.

Cardiovascular effects of ephedra alkaloids: a comprehensive review.

Andraws R, Chawla P, Brown DL.

Prog Cardiovasc Dis. 2005 Jan-Feb;47(4):217-25. Review.

PMID:
15991150
[PubMed - indexed for MEDLINE]
17.

Content versus label claims in ephedra-containing dietary supplements.

Gurley BJ, Gardner SF, Hubbard MA.

Am J Health Syst Pharm. 2000 May 15;57(10):963-9.

PMID:
10832496
[PubMed - indexed for MEDLINE]
18.

FDA issues alert on ephedra supplements in the USA.

Nelson R.

Lancet. 2004 Jan 10;363(9403):135. No abstract available.

PMID:
14733193
[PubMed - indexed for MEDLINE]
20.

Ephedra: heart dangers in disguise.

[No authors listed]

Consum Rep. 2004 Jan;69(1):22-3. No abstract available.

PMID:
14677546
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk